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Elaidic acid is a trans-fatty acid found in many food products and implicated for having potentially health hazardous effects in humans. Elaidic
acid is readily incorporated into membrane lipids in vivo and therefore affects processes regulating membrane physical properties. In this study the
membrane properties of sphingomyelin and phosphatidylcholine containing elaidic acid (N-E-SM and PEPC) were determined in bilayer membranes
with special emphasis on their interaction with cholesterol and participation in ordered domain formation. In agreement with previous studies the
melting temperatures were found to be about 20 °C lower for the elaidoyl than for the corresponding saturated lipids. The trans-unsaturation
increased the polarity at the membrane–water interface as reported by Laurdan fluorescence. Fluorescence quenching experiments using
cholestatrienol as a probe showed that both N-E-SM and PEPC were incorporated in lateral membrane domains with sterol and saturated lipids. At
low temperatures the elaidoyl lipids were even able to form sterol-rich domains without any saturated lipids present in the bilayer. We conclude from
this study that the ability ofN-E-SM and PEPC to form ordered domains together with cholesterol and saturated phospho- and sphingolipids in model
membranes indicates that they might have an influence on raft formation in biological membranes.
© 2007 Elsevier B.V. All rights reserved.Keywords: Phosphatidylcholine; Sphingomyelin; Cholestatrienol; Trans-parinaric acid; Fluorescence quenching; Laurdan1. Introduction
Trans-unsaturated fatty acids are produced from their cis-
isomers during partial hydrogenation procedures used by the
food industry to harden oils. Trans-fatty acids are consequently
found in a variety of food products. Industrially produced trans-
fatty acids have received some attention lately due to theirAbbreviations: 7SLPC, 1-palmitoyl-2-stearoyl-(7-doxyl)-sn-glycero-3-
phosphocholine; CTL, cholestatrienol; β-CyD, β-cyclodextrin; DPH, 1,6-
diphenyl-1,3,5-hexatriene; HDL, high-density lipoprotein; Laurdan, 6-lauroyl-
2-(N,N-dimethylamino)naphthalene; LDL, low-density lipoprotein; NMR,
nuclear magnetic resonance; N-E-SM, D-erythro-N-elaidoyl-sphingomyelin;
N-O-SM, D-erythro-N-oleoyl-sphingomyelin; N-S-SM, D-erythro-N-stearoyl-
sphingomyelin; PC, phosphatidylcholine; PEPC, 1-palmitoyl-2-elaidoyl-sn-
glycero-3-phosphocholine; PGalCer, N-palmitoyl-galactosylceramide; PGlcCer,
N-palmitoyl-glucosylceramide; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine; PSPC, 1-palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine;
SM, sphingomyelin; Tm, gel–liquid crystalline transition temperature; tPA, trans-
parinaric acid
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doi:10.1016/j.bbamem.2007.04.009potentially hazardous health effects [1–4]. Like saturated fatty
acids, also trans-fatty acids seem to cause an elevation in blood
LDL, whereas trans-fatty acids in contrast to saturated fatty
acids also lower the blood HDL [5,6]. The effect of trans-fatty
acids on blood LDL/HDL ratio can therefore be even more
severe than that of saturated fatty acids [2,5]. Epidemiological
studies have also found that the consumption of trans-fatty
acids increases the risk of coronary heart disease, sudden death
and possibly also diabetes mellitus [2,4]. These reports have
recently led to legislation concerning high trans-fatty acid food
in some countries. Denmark has decided to reduce the trans-
fatty acid content of food remarkably during the last 2 years [4].
In some countries (e.g. the US) the amount of trans-fatty acids in
food products must be declared on nutritional information labels
[7]. Although epidemiological studies have shown serious
health complications associated with the intake of trans-fatty
acids their mechanism of action is yet poorly studied at the
molecular level.
It was established already in the 1970s that trans-fatty acids
taken up from the diet are incorporated into higher lipids such as
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major man made trans-fatty acid ending up in humans is elaidic
acid (18:1Δ9t) and this is also the trans-fatty acid that has been
most widely used in trans-fat related studies. Elaidic acid is
readily incorporated into membrane lipids in vivo and therefore
comes to function as an effector in the processes regulating
membrane physical properties [11–13]. The order in the trans-
fatty acid containing phospholipid membranes has been shown
to be higher than with the cis-analogues [13,14]. Melting tem-
peratures (Tm) for phospholipids are also much less affected by
mono-trans-unsaturation compared to the corresponding cis-
unsaturation. This can be exemplified by the phosphatidylcho-
lines used in this study for which the Tm-values have been
reported to be 49 °C for PSPC (1-palmitoyl-2-stearoyl-sn-
glycero-3-phosphocholine), −2.5 °C for POPC (1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine) as measured by differential
scanning calorimetry [11] and 26 °C for PEPC (1-palmitoyl-2-
elaidoyl-sn-glycero-3-phosphocholine) as measured by loss of
deuterium NMR signal [12]. Computer simulations have
confirmed that the configuration of a trans-unsaturated chain
in phosphatidylcholine closely resembles that of a saturated
chain [15]. A cis-unsaturation in the middle of the acyl chain
will on the other hand interfere considerably with the hydro-
carbon chain packing in the core of the bilayer [16]. However,
when looking at the interactions at the membrane–water
interface molecular dynamics simulations show that the effect
of a trans-unsaturated acyl chain in a PC molecule differs only
slightly from that of a cis-unsaturated chain [17]. It seems clear
from the above mentioned studies that membrane lipids
containing trans-unsaturated acyl chains have properties that
differ clearly from the corresponding saturated as well as cis-
unsaturated lipids.
Biological membranes are heterogeneous with both trans-
verse and lateral asymmetry of lipids. It has been shown that
cholesterol and sphingomyelin co-localize in biological mem-
branes and that they, together with glycosphingolipids and
perhaps some saturated glycerophospholipids, form detergent
insoluble membrane domains, also called rafts [18,19]. These
rafts have been suggested to take part in cellular processes, for
example signal transduction, membrane trafficking and protein
sorting [18,20–23]. The domains form as a consequence of non-
ideal mixing of membrane lipid components which leads to
segregation of certain lipids [24]. Domains formed in bilayer
membranes may then be stabilized by lipid–lipid interactions
such as attractive van der Waal's forces between the saturated
acyl-chains of the sphingolipids involved and possible hydrogen
bonding in the head group and interfacial regions [18,20–23].
Since trans-unsaturated phospholipids alter bulk membrane
properties, the question of how these lipids influence membrane
lateral domains becomes highly relevant.
Cholesterol is localized to the plasma membranes in mam-
malian cells where it is the major neutral lipid component [25]. In
themembrane bilayer cholesterol influences the physical state and
packing density of phospholipids. The degree of intermolecular
interactions between cholesterol and different phospholipids and
the way the lipids are packed together in the bilayer is known to
vary [26]. The interaction between cholesterol and trans-fattyacid containing phospholipids was recently studied by measuring
the cholesterol partition coefficient between a cholesterol–
cyclodextrin complex and large unilamellar vesicles containing
the phospholipid [14]. The authors concluded that membranes
containing trans-unsaturated phospholipids had a larger choles-
terol affinity than corresponding cis-unsaturated phospholipid
membranes. Studies of trans-fatty acid containing sphingolipids
are scarce. Isolation of detergent resistant membrane domains
from large unilamellar vesicles containing natural glyceropho-
spholipids and different acyl chain defined sphingomyelin spe-
cies, including N-elaidoyl-sphingomyelin (N-E-SM) together
with cholesterol have been conducted. No detergent resistant
domainswere formed by cholesterol andN-oleoyl-sphingomyelin
(N-O-SM), whereas N-E-SM formed detergent resistant domains
but not to as large an extent as N-stearoyl-sphingomyelin (N-S-
SM, [27]). In this study we wanted to explore how phosphati-
dylcholine and sphingomyelin containing an elaidoyl acyl chain
behave in complex lipid bilayers.
2. Materials and methods
2.1. Materials
Cholesterol was purchased from Sigma Chemicals (St. Louis, MO, USA).
D-erythro-N-stearoyl-sphingomyelin (N-S-SM) was purified from egg yolk
sphingomyelin (Avanti Polar Lipids, Alabaster, AL, USA) by reverse-phase
HPLC (Supelco Discovery C18-column, dimensions 250×21, 2 mm, 5 μm
particle size, with 100% methanol as the mobile phase). The purity and identity
of the product was verified on a Micromass Quattro II mass spectrometer
(Manchester, UK). D-erythro-N-elaidoyl-sphingomyelin (N-E-SM) and D-ery-
thro-N-oleoyl-sphingomyelin (N-O-SM) were synthesized from D-erythro-
sphingosylphosphorylcholine (Avanti Polar Lipids) and trans-9-octadecenoic
acid or cis-9-octadecenoic acid, respectively (Sigma Chemicals) [28]. N-Palmitoyl-
galactosylceramide (PGalCer) and N-palmitoyl-glucosylceramide (PGlcCer)
were synthesized from corresponding lyso derivatives (Avanti Polar Lipids)
and palmitic acid anhydride (Sigma Chemicals) as described previously [29].
1-Palmitoyl-2-oleyl-sn-glycero-3-phosphocholine (POPC) was obtained from
Avanti Polar Lipids. (7-Doxyl)-stearic acid (TCI Europe N.V., Belgium) and 1-
palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (Avanti Polar Lipids)
were used for the synthesis of 1-palmitoyl-2-stearoyl-(7-doxyl)-sn-glycero-
3-phosphocholine (7SLPC) [30]. Octadecanoic acid (Larodan Fine Chemi-
cals) and 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (Avanti Polar
Lipids) were used for the synthesis of 1-palmitoyl-2-stearoyl-sn-glycero-3-
phosphocholine (PSPC) [30]. Trans-9-octadecenoic acid (Sigma Chemicals)
and 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (Avanti Polar
Lipids) were used for the synthesis of 1-palmitoyl-2-elaidoyl-sn-glycero-3-
phosphocholine (PEPC) [30]. All products were purified by HPLC and
characterized by mass spectrometry. Stock solutions of lipids were prepared in
hexane/2-propanol (3:2 by vol), stored in the dark and warmed to ambient
temperature before use. β-cyclodextrin (β-CyD) was obtained from Sigma
Chemicals and stock solution prepared in H2O to a concentration of 40 mM.
The water used in all experiments was purified by reverse osmosis followed by
passage through a Millipore UF Plus water purification system, to yield a
product with a resistivity of 18.2 MΩcm. 1,6-diphenyl-1,3,5-hexatriene
(DPH) and 6-lauroyl-2-(N,N-dimethylamino)naphthalene (Laurdan) were
obtained from Molecular Probes (Leiden, The Netherlands).
Cholesta-5,7,9(11)-trien-3-beta-ol (CTL) was synthesized and purified using
the method published by Fisher and coworkers [31]. CTL was purified in the dark
by reverse-phase HPLC on a RP-18 column with methanol/acetonitrile (30:70, by
vol) as eluent and positively identified by mass spectrometry. Cholesterol (99+%
pure) was obtained from Sigma Chemicals. Trans-parinaric acid (tPA) was
obtained fromMolecular Probes (Eugene, OR,USA).CTL and tPAwere stored dry
under argon in the dark at −87 °C until solubilised in argon-purged ethanol (CTL)
or methanol (tPA). Stock solutions of CTL and tPA were stored in the dark at
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were always protected from light and the solvents saturated with argon to minimize
the risk of oxidation.
2.2. Preparation of vesicles
Vesicles used in steady-state fluorescence measurements and in determina-
tion of steady-state fluorescence anisotropy were prepared to a lipid concen-
tration of 50 μM. The lipid mixtures were dried under nitrogen, dissolved in
benzene or hexane/2-propanol (3:2 by vol), redried under nitrogen and finally
kept in vacuum at 22 °C for at least 30 min. The dry lipids were dispersed in
argon-purged water and heated above the gel- to liquid-crystalline phase-tran-
sition temperature. The warm samples were briefly vortexed and sonicated for
2 min (25% duty cycle, power output 10W) with a Branson probe sonifierW-450
(Branson Ultrasonics, Danbury, CT, USA). This procedure gives liposomes with
a rather large size distributionwith amean diameter of 200 nm (determinedwith a
Malvern 4700 multiangle laser spectrometer at an angle of 90°).
In fluorescence quenching studies of sphingomyelins and glyceropho-
spholipids, F samples consisted of POPC/7SLPC/variable phospholipid(s)/
cholesterol (30:30:30:10, mol%) in F0 samples POPC replaced 7SLPC. The
30 mol% phospholipid-fraction was either N-S-SM, N-E-SM, N-S-SM/N-E-SM
(50:50, molar ratio), PSPC, PEPC or PSPC/PEPC (50:50, molar ratio). The
samples were studied with CTL or tPA as the fluorescent probe. CTL replaced
1 mol% of cholesterol and tPA replaced 1 mol% of POPC.
In the fluorescence quenching studies examining the domain forming ability of
glycosphingolipids and sphingomyelins, F samples consisted of POPC/7SLPC/
variable sphingomyelin/variable glycosphingolipid/cholesterol, (30:30:15:15:10,
mol%), in F0 samples POPC replaced 7SLPC. The variable sphingomyelin was
either N-S-SM or N-E-SM and the variable glycosphingolipid was either PGalCer
or PGlcCer. The samples were studied with CTL or tPA as the fluorescent probe.
The samples prepared for steady-state fluorescence anisotropy consisted of
phospholipid with 0.5 mol% of DPH as fluorescent probe. The phospholipid
was either N-S-SM, N-E-SM, PSPC or PEPC.
2.3. Fluorescence measurements
The fluorescence quenching method has been described in detail in a
previous study [32]. Briefly, lipid vesicles containing ordered and disordered
domains were prepared, where POPC and the nitroxide labeled quencher 7SLPC
made up the bulk of the disordered phase and the composition of the ordered
phase varied. The fluorescence intensity in the F samples was compared to the
fluorescence intensity in the F0 samples giving the fraction of quenched fluo-
rescence. The fluorescent probes residing in the ordered phase were protected
from quenching by 7SLPC. The melting of ordered domains was seen as a
decrease in fluorescence intensity when the probes come in closer contact with
the quencher due to increased homology. Other possible explanations for in-
creased quenching at higher temperature, such as vesicle rupture or merging,
have been ruled out by cooling and re-heating the samples and thereby con-
cluding that the process is reversible and reproducible. CTL is a fluorescent
cholesterol analogue that has been shown to mimic the behavior of cholesterol
quite well [31,33–36] and resides in cholesterol-rich ordered domains. It has
previously been shown that tPA generally resides in ordered phases also when
these are in the gel phase [29,37,38]. The quenching curves of CTL and tPA
therefore indicate the extent of sterol-rich and ordered domain formation,
respectively.
Steady-state fluorescence measurements were performed on a PTI Quanta-
Master-1 spectrofluorimeter (Photon Technology International, Lawrenceville,
NJ, USA). The excitation slits were set to 1 nm for tPA and 5 nm for CTL, the
emission slits were set to 5 nm for both fluorescent probes. The temperature was
controlled by a Peltier element, with a temperature probe immersed in the
sample solution. The samples were heated from 8 °C to 70 °C with a temperature
gradient of 5 °C/min. The measurements were performed in quartz cuvettes and
the solutions were kept at a constant stirring rate of 260 rpm during the entire
experiments. Fluorescence intensity for CTL was detected with excitation and
emission wavelengths of 324 nm and 374 nm, respectively. For tPA fluorescence
intensity was detected with excitation and emission wavelengths of 305 nm and
410 nm, respectively. All experiments were performed in at least duplicates and
curves shown are representative of reproducible experiments.2.4. Determination of steady-state anisotropy
The vesicles were prepared as described above. The measurements were
performed on a PTI QuantaMaster-1 spectrofluorimeter (Photon Technology
International) operating in the T-format. The samples were heated from 8 °C to
70 °C with a temperature gradient of 5 °C/min. The DPH fluorescence was
detected with excitation and emission wavelengths of 360 nm and 430 nm,
respectively. The steady-state anisotropy, r, was determined as described in [39].
All experiments were performed in at least duplicates and curves shown are
representatives of reproducible experiments.
2.5. Laurdan emission measurements
Sonicated vesicles containing pure phospholipids and 0.5 mol% Laurdan as a
reporter molecule were prepared by probe sonication as described above. Laurdan
emission spectra were recorded between 390 and 550 nmwith a PTI QuantaMaster
1 spectrofluorimeter. The excitationwavelengthwas set at 365 nm.The generalized
polarization (GP) values indicating the position of the Laurdan emission spectra
were calculated as
GP ¼ ðI435  I505Þ=ðI435  I505Þ
where I435 is the fluorescence intensity in the blue-shifted region (435 nm) of the
emission spectrum and I505 is the corresponding red-shifted emission intensity (at
505 nm) [42]. The Laurdan emission measurements were recorded at indicated
temperatures between 5 and 70 °C.
2.6. Cholesterol desorption
Desorption of cholesterol from mixed monolayers to β-cyclodextrin in
the subphase was determined according to a previously described procedure
[40]. Briefly, mixed monolayers containing 60 mol% cholesterol and either
N-S-SM, N-E-SM, PSPC or PEPC were prepared at the air/water interface.
The trough used was of a zero-order type with a reaction chamber (volume:
23.9 ml, area: 28.3 cm2) separated by a glass bridge from the lipid reser-
voir. The monolayer was compressed to 20 mN/m at 22 °C, given time
to stabilize (∼5 min) and then kept at this pressure during the entire
experiment. β-CyD was injected into the reaction chamber (volume not
exceeding 1 ml) to a final concentration of 1.7 mM; the content of the
reaction chamber was continuously stirred. The cholesterol desorption rate
was calculated from the area decrease of the monolayer at constant surface
pressure during the first 10 min after injection of β-CyD. All experiments
were performed at least three times and the results are given as the mean±
standard deviation.
3. Results
In order to define the gel–fluid phase transition temperatures
of the saturated and trans-unsaturated phospholipids used in the
study, we determined the steady-state anisotropy of DPH in
multilamellar liposomes, containing 99.5 mol% of the phos-
pholipid and 0.5 mol% of the fluorescent reporter molecule, as a
function of increasing temperature (Fig. 1). The mid-point of the
anisotropy transition occurred at about 23, 27, 42 and 48 °C for
N-E-SM, PEPC, N-S-SM and PSPC, respectively, in fairly good
agreement with previous data, where available [11,12,41].
Hence, there was about 20 °C difference in the melting of N-E-
SM and N-S-SM, or PEPC and PSPC, respectively, due to the
introduction of a single trans-unsaturation in the N-linked or sn-
2 position of the respective phospholipid. The difference in
melting temperature appeared not to be affected by the interfacial
properties of the phospholipids. The degree of anisotropy in the
bilayers entering the liquid phase (e.g. at Tm+5 °C) appeared not
to be dependent on the acyl chain composition, but were on the
Fig. 2. Laurdan GP values measured as a function of temperature. Pure vesicles
containing N-S-SM, N-E-SM, PSPC or PEPC and 0.5 mol% Laurdan as a
reporter molecule were prepared by probe sonication. Laurdan emission spectra
were recorded at indicated temperatures between 390 and 550 nm with a PTI
QuantaMaster 1 spectrofluorimeter. The excitation wavelength was set at
365 nm and the GP values calculated from the fluorescence emission intensities
in the blue-shifted region at 435 nm and in the red-shifted region at 505 nm.
Fig. 1. Steady-state anisotropy of DPH in vesicles containing sphingomyelins or
phosphatidylcholines. The vesicles were prepared from N-S-SM, N-E-SM,
PSPC or PEPC, with 0.5 mol% DPH as the reporter molecule, by probe
sonication at temperatures exceeding the transition temperature of the
phospholipids. The lipid concentration was 50 μM and the temperature gradient
was 5 °C/min.
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and lower in PC bilayers; Fig. 1).
The polarity differences at the membrane–water interface
were studied by measuring the Laurdan emission intensities in
the different lipid environments and calculating the GP-values
for these. The fluorescence properties of Laurdan are sensitive to
the changes in polarity in the local environment of the probe at
the membrane–water interface [42]. The GP values are higher in
the gel than in the fluid phase bilayer due to the less polar
environment of the probe in the former. Sphingomyelins have
previously been shown to give more red-shifted Laurdan spectra
and hence lower GP-values than corresponding phosphatidyl-
cholines [43]. Fig. 2 shows the Laurdan GP at different
temperatures in pure PEPC and N-E-SM vesicles comparing
them to those in corresponding vesicles containing stearoyl
lipids. The trans-unsaturation increased the polarity of the
membrane–water interface. Of the four lipids studied N-E-SM
seems to offer the most polar environment for the Laurdan probe
especially at temperatures below the phase-transition. Although
the order in the sphingomyelin bilayers below the melting tem-
perature is higher in the acyl-chain region as measured by DPH
anisotropy (Fig. 1) the properties at the membrane–water inter-
face seem to resemble the fluid phase more in SM than in the
corresponding PC bilayers (Fig. 2). The melting temperatures
recorded as a decrease in GP-values for Laurdan are in good
agreement with those reported by DPH-anisotropy.
The formation of ordered domains by the trans-monounsat-
urated phospholipids was determined in a POPC matrix using
either CTL, as a marker for sterol-rich domains, or tPA, as a
marker for ordered domains in general, and 7SLPC as the
quencher in the sterol-poor POPC-rich domain [29,32]. Fluores-
cence emission intensity was measured in F samples consisting
of POPC:7SLPC:phospholipid:cholesterol:probe (30:30:30:9:1,molar ratio) and compared to F0 samples, in which 7SLPC was
replaced by POPC. A high F/F0 ratio thereby shows that the
probe in the ordered phase is shielded from quenching and
indicates the presence of ordered (as reported by tPA) and
sterol-rich (as reported by CTL) domains in the bilayers. As the
diffusion in the bilayer increases and the domains become
smaller or more dispersed with increasing temperature the F/F0
ratio goes down as the probes come in contact with the
quencher. The latter process is what we here refer to as “domain
melting”. The ratio F/F0 for different bilayer compositions is
plotted as a function of temperature in Fig. 3. The top panels
depict bilayers in which CTL was used, whereas tPA was used
for bilayer systems shown in the bottom panels. The ordered
domains formed by sterols and the saturated N-S-SM and PSPC
were the most thermostable, with melting completed around
35–37 °C (Fig. 3A and B). The trans-monounsaturated phos-
pholipids, N-E-SM and PEPC, also appeared to form domains
that included CTL, however these domains were much less
thermostable (fully melted at 18 and 14 °C, for N-E-SM and
PEPC, respectively) as compared to the saturated counterparts.
Equimolar mixtures of N-S-SM and N-E-SM, or PSPC and
PEPC formed sterol-enriched domains that were intermediate in
thermostability compared to the respective control situations
(Fig. 3A and B).
The low melting temperature of the domains formed by the
trans-monounsaturated phospholipids, together with the tech-
nical limitations of our instrumentation, prevented us from
recording the complete melting profile of the domains. Thus the
melting amplitude remains unknown for the trans-monounsat-
urated species. However, for the SM system, the mixed N-E-
SM/N-S-SM domains had only half of the F/F0 amplitude as
compared to the N-S-SM domains (Fig. 3A and B), suggesting a
lower affinity of CTL (and cholesterol) for these domains. In the
Table 1
Rate of cholesterol desorption from mixed monolayers to β-cyclodextrin in the
subphase a
Monolayer composition (40/60 mol%) Desorption rate (pmol cm−2 min−1)
N-S-SM/Cholesterol 2.4±0.0
N-E-SM/Cholesterol 7.3±1.1
N-O-SM/Cholesterol 10.2±0.4
PSPC/Cholesterol 8.3±1.0
PEPC/Cholesterol 13.1±1.7
POPC/Cholesterol 15.6±0.3
β-CyDwas injected into the reaction chamber to a final concentration of 1.7 mM
under continuous stirring. The cholesterol desorption rate was calculated from
the area decrease of the monolayer during the first 10 min after injection of β-
CyD. The standard deviations given were calculated from at least three
experiments.
a Mixed monolayers were prepared at the air/water interface, compressed to
20 mN/m at 22 °C and kept at this pressure during the entire experiment.
Fig. 3. Melting of phospholipid/cholesterol-rich ordered domains in a fluid bilayer as examined by quenching of CTL (A, B) and tPA (C, D). F samples consisted of
POPC/7SLPC/variable phospholipid(s)/cholesterol (30:30:30:10, mol%) in F0 samples POPC replaced 7SLPC. The variable phospholipid was either N-S-SM, N-E-
SM, PSPC, PEPC or a combination consisting of 15 mol% of two of the phospholipids. CTL and tPA were used as reporter molecules and replaced 1 mol% of
cholesterol or POPC, respectively. The total lipid concentration was 50 μM and the temperature gradient was 5 °C/min.
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also slightly diminished compared to the PSPC system.
When tPA was used to probe the thermostability of the
domains formed by saturated or trans-monounsaturated phos-
pholipids, very similar melting temperatures could be seen for
the PC bilayers as when CTL was used (Fig. 3D and B,
respectively). However, with membranes containing SMs, the
tPA reported slightly higher melting temperatures as compared
to CTL (Fig. 3C and A, respectively). tPA is known to be able to
associate with and increase the melting temperature of ordered
membrane lipids [44,45], and apparently tPA stabilized SM-
domains more than PC domains.
The rate of cholesterol desorption is known to be markedly
affected by the strength of cholesterol/phospholipid interaction
in the donor membrane [46]. Consequently, the rate of cho-
lesterol desorption to β-CyD can be used as a measure of how
well cholesterol interacts with phospholipids in a monolayer
[40]. Table 1 shows the desorption rates of cholesterol from
mixed monolayers containing 60 mol% cholesterol and 40 mol
% phospholipid to β-CyD in the subphase. Our results show
that the cholesterol desorption from monolayers with trans-unsaturated species of sphingomyelin and phosphatidylcholine
(N-E-SM and PEPC) was lower than from the cis-unsaturated
and higher than from the saturated counterparts. Cholesterol
desorption was also constantly lower from sphingomyelin
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phatidylcholines, in line with previous findings [47].
We have previously shown that while saturated cerebrosides
are able to form ordered domains in complex bilayers, sterols do
not appear to associate with such ordered domains to any greater
extent [29]. However, when saturated sphingomyelin was
included in the cerebroside domains, also sterols become
associated with the ordered domains [29]. In order to study
whether N-E-SM (or N-S-SM) was able to associate with
cerebrosides in complex bilayers, we performed quenching
experiments on the following bilayer compositions: F samples
contained POPC/7SLPC/SM/cerebroside/sterol (30/30/15/15/
10) while F0 samples contained POPC instead of the 7SLPC.
The fluorescent probe was CTL (replaced 1 mol% of cho-
lesterol) or tPA (replaced 1 mol% of POPC). In control bilayers
30 mol% cerebroside was the sole ordered lipid.
As seen in Fig. 4A and B, CTL (and cholesterol) was not able
to form sterol-enriched domains in POPC bilayers containing
30 mol% of PGalCer, in full agreement with our previous
reports on similar bilayer systems [29,32]. With 30 mol%Fig. 4. Melting of ordered domains in complex glycosphingolipid containing flu
glycosphingolipids examined were PGalCer (A, C) and PGlcCer (B, D). Th
glycosphingolipid/cholesterol (30:30:15:15:10, mol%), in the F0 samples POPC repl
sphingomyelin) was used. CTL and tPAwere used as reporter molecules and replaced
50 μM and the temperature gradient was 5 °C/min.PGlcCer some sterol-enriched domains apparently formed,
since there is a small discontinuity in the F/F0 function around
30 °C (Fig. 4B—see also Fig. 1A in [29]). The presence of
PGalCer or PGlcCer in the POPC matrix led to the formation of
ordered domains, as reported by tPA (Fig. 4C and D), melting
around 43 °C. However, inclusion of N-S-SM with either
PGalCer or PGlcCer (equimolar mixture) led to the formation of
sterol-enriched domains which readily shielded CTL from
quenching by 7SLPC at low temperature (Fig. 4A and B), and
which melted at 41–42 °C. Previously we reported that PSM
together with either PGalCer or PGlcCer was able to form
sterol-enriched domains [29]. Interestingly, N-E-SM was also
able to loosen up the molecular packing of the cerebrosides and
allow sterol to enrich in the ordered N-E-SM/cerebroside do-
mains. The N-E-SM-containing cerebroside domains melted at
a 10 °C lower temperature as compared to the N-S-SM/
cerebroside domains (as reported by CTL—Fig. 4A and B).
Using tPA as the reporter molecule, the melting of pure
PGalCer and PGlcCer domains in the POPC matrix was clearly
seen (Fig. 4C and D—see also Fig. 1C in [29]). The end ofid bilayers as examined by quenching of CTL (A, B) and tPA (C, D). The
e F samples consisted of POPC/7SLPC/ variable sphingomyelin/variable
aced 7SLPC. As reference a sample with 30 mol% glycosphingolipid (replacing
1 mol% of cholesterol or POPC, respectively. The total lipid concentration was
1845A. Björkbom et al. / Biochimica et Biophysica Acta 1768 (2007) 1839–1847melting of PGlcCer domains (with tPA) was slightly higher
(a few degrees Celsius) in this study than in Maunula et al., and
may relate to small differences in the concentration of the
PGlcCer in these two studies. The melting temperatures for the
mixed domains were rather similar as reported by CTL or tPA,
except for the PGalCer/N-S-SM system which showed a slightly
higher end of melting with tPA than with CTL as probe.
4. Discussion
This work represents a study of the properties of trans-
unsaturated lipids in complex bilayer membranes, with special
emphasis on their interaction with cholesterol and participation
in ordered domain formation. Since trans-fatty acids have
serious health implications and they are readily incorporated
into phospholipids in vivo the properties of such lipids in
membranes are of critical importance to understanding the
phenomena underlying their effects. Elaidic acid, which is the
trans-fatty acid used in this study, is produced by partial hydro-
genation processes used by the food industry for cultivating
oils. Elaidic acid is taken up from the diet and eventually
incorporated into complex lipids in membranes.
Trans-unsaturations can be incorporated into a saturated fatty
acid without affecting the tilt of the acyl chains in a bilayer
structure [48]. In contrast, accommodation of cis-double bonds
requires a change of chain tilt. Consequently trans-fatty acids
have a more linear structural shape than the corresponding cis-
isomers. Also when incorporated into phospholipids trans-fatty
acids have been shown to behave like and produce membrane
properties which are more similar to saturated than to cis-
unsaturated lipids [13,14]. The melting temperatures reported
here for both sphingomyelin and phosphatidylcholine were
shown to be substantially lower for the elaidoyl- compared to
the stearoyl-species. The trans-unsaturation also increased the
polarity of the interface according to Laurdan GP-measure-
ments at most temperatures studied. However, the properties of
the membrane–water interface for bilayer vesicles composed of
PSPC and PEPC were very similar both in liquid–crystalline
and gel-phase according to Laurdan. For the sphingomyelins the
environment at the interface in the N-E-SM vesicles seemed to
always be more polar than in the N-S-SM bilayers. However,
the properties at the interface as measured by Laurdan GP were
significantly different for the trans-unsaturated lipids as com-
pared to the cis-unsaturated (POPC or N-O-SM, results not
shown) in contrast to what computer simulations have indicated
[17].
Studies on trans-parinaric acid (tPA) containing four con-
jugated trans-double bonds have shown a preferential association
of these fatty acids with solid phase lipids [44,45]. Trans-
unsaturations therefore seem to allow tight enough packing of the
acyl chains to favor partitioning into ordered phases. This was
clearly seen for the elaidoyl-lipids in this study when domain
formation was studied with tPA as the fluorescent marker. Both
PEPC and N-E-SM formed ordered domains at low temperatures
and they also participated in ordered domain formation together
with the saturated counterparts. The elaidoyl chain in phospha-
tidylcholine has been shown by computer simulations to have anearly identical configuration to a saturated stearic chain in the
corresponding position [13,49]. In this study, the trans-unsatura-
tion did not seem to affect the miscibility with the saturated
counterparts to any larger extent, since these were able to form
ordered domains together. N-E-SM was further shown to partic-
ipate in ordered domain formation with the neutral glyco-
sphingolipids (PGalCer and PGlcCer). These glycosphingolipids
have high Tm values and exhibit tight lateral packing in bilayer
membranes, due to their saturated hydrophobic parts and the
opportunity to form hydrogen-bonding networks in the head
group region [19,50]. Such neutral glycosphingolipids also have
the ability to form tightly packed gel-phase microdomains in
bilayer membranes [29,51]. It was therefore interesting to see that
the elaidoyl-lipids were able to mix and form ordered domains
together with GalCer and GlcCer.
Cis-unsaturations in the acyl chains of phosphatidylcholines
and sphingomyelins have been shown to greatly interfere with
their interaction with cholesterol [47,52,53]. The partitioning of
cholesterol into membranes containing either a trans- or a cis-
unsaturated phospholipid showed a clear preference of choles-
terol for the trans-unsaturated membranes [14]. We show in this
study that domains comprised of the elaidoyl-lipids and choles-
terol can be formed in complex bilayer membranes. N-E-SM
was even able to participate in ordered domain formation with
cerebrosides in a way that promoted sterol partitioning into the
domains. Our results are in good agreement with previously
published results that showed detergent resistant membranes
containing sterol and N-E-SM [27]. We also show, however,
that the sterol-rich domains formed with the elaidoyl lipids will
melt at substantially lower temperatures than domains formed
by the saturated counterparts. Also, we see that the cholesterol
desorption from monolayers to β-CyD in the subphase from
monolayers containing the trans-unsaturated lipids will be of
intermediate rate compared to that from saturated and cis-
unsaturated monolayers, respectively. It is therefore apparent
that cholesterol has an intermediate affinity for the elaidoyl
lipids in the monolayers. The cholesterol interaction with
sphingomyelin differs from that with phosphatidylcholines
[26,47,54–56]. We can see that clearly also from the cholesterol
desorption data in this study showing significantly higher
desorption rates from phosphatidylcholines than from the acyl
chain matched sphingomyelins.
We conclude that N-E-SM and PEPC participate in ordered
domain formation with cholesterol and saturated phospho- and
sphingolipids which suggests that they might also participate in
raft-formation in biological membranes. The trans-unsaturation
reduces the melting temperatures of both the pure lipids in
bilayers and of ordered domains containing these lipids when
compared to the saturated counterparts. The properties seen for
these lipids in our study support the notion that trans-fatty acids
from our diet may alter the basic properties of biological
membranes substantially when incorporated into membrane
lipids [5,57,58] and thereby mediate effects on membrane bound
receptors [59]. The effects seen here for N-E-SM and PEPC on
fluidity and lateral domain formation in bilayers may therefore
be involved in the pathological conditions associated with trans-
unsaturated lipids.
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